Literature DB >> 23276054

The quality of prescription drug utilization five years after the 2003 Bam earthquake.

Gholamreza Sepehri1, Naser Haj-Akbari, Ehsan Sepehri, Motahareh Mohsen-Beigi.   

Abstract

PURPOSE: Few reports considering drug use among earthquake survivors exist. The present study aims to examine the Bam earthquake's impact on prescribing patterns and drug use among residents five years post-disaster. DESIGN/METHODOLOGY/APPROACH: In this study, 297,104 prescriptions, issued by general practitioners in Bam city in 2008, were investigated for drugs/prescriptions, drug name, drug category, using WHO appropriate general practice prescribing indicators.
FINDINGS: Mean drugs per prescription was 3.1. Drugs affecting the central nervous system were the most frequently used among Bam residents, representing 25.1 per cent, followed by antimicrobials, respiratory, cardiovascular and gastrointestinal tract drugs. Benzodiazepines were the most frequently used central nervous system drugs (15.8 per cent) followed by narcotic analgesics and tricyclic antidepressants. Penicillins (6.4 per cent) and cephalosporines (2.3 per cent) were the most frequently used antimicrobial drugs. ORIGINALITY/VALUE: Results emphasize increased drug use for psychological disturbances and the need for strategies to improve mental health among disaster survivors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23276054     DOI: 10.1108/09526861211261181

Source DB:  PubMed          Journal:  Int J Health Care Qual Assur        ISSN: 0952-6862


  2 in total

1.  Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran.

Authors:  Abdolreza Sabahi; Gholamreza Sepehri; Mottahareh Mohsenbeigi; Ehsan Sepehri
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

Review 2.  Antibiotic prescribing in inpatient and outpatient settings in Iran: a systematic review and meta-analysis study.

Authors:  Ehsan Nabovati; Zhila TaherZadeh; Saeid Eslami; Ameen Abu-Hanna; Reza Abbasi
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-14       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.